Basit öğe kaydını göster

dc.contributor.authorBorazan, Ersin
dc.contributor.authorYaylim, Ilhan
dc.contributor.authorHorozoglu, Cem
dc.contributor.authorNacarkahya, Gulper
dc.date.accessioned2022-07-04T12:31:42Z
dc.date.available2022-07-04T12:31:42Z
dc.date.issued2022
dc.identifier.citationNacarkahya G., Borazan E., Horozoglu C., Yaylim I., "Investigation of Long Non-coding RNAs H19 and LINC00675 in Colorectal Cancers in Terms of Histopathological Features and Correlations With Plasma Markers", ANTICANCER RESEARCH, cilt.42, sa.3, ss.1301-1306, 2022
dc.identifier.issn0250-7005
dc.identifier.otherav_203b72a3-e8c7-4493-9a8c-c1050f554ce6
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181899
dc.identifier.urihttps://doi.org/10.21873/anticanres.15597
dc.description.abstractBackground/Aim: Functional and bioinformatic studies provide strong evidence that long non-coding RNAs (lncRNAs) can alter the molecular mechanisms of cancer through their interactions with DNA, RNAs, and proteins. This study aimed to evaluate the role of H19 and LINC00675 lncRNAs in colorectal cancers (CRCs) in terms of clinicopathological features. Materials and Methods: Tumor and tumor-free surrounding tissue samples were obtained from 51 CRC cases. Total RNA isolation and cDNA synthesis were performed. qPCR was performed using the TaqMan non-coding lncRNA assay specific for H19 and LINC00675. Preoperative levels of plasma markers, lncRNA expression, and clinicopathological characteristics of the cases were evaluated statistically. Results: Expression of H19 in tumor tissue was found to be 2.11 times higher than that of tumor-free surrounding tissue (p<0.001). LINC00675 levels were found to be approximately three times higher in colon tumors than tumors with rectal involvement (p=0.019). There was a correlation between H19 expression and creatinine (r=0.408; p=0.003). In addition, correlations were detected between LINC00675 with albumin (r=0.303; p=0.03), and between LINC00675 with globulin (r=0.332; p=0.02). Conclusion: H19 is a candidate biomarker that can be evaluated in terms of prognosis and antineoplastic treatment response, while LINC00675 may be an important marker of the microenvironment of advanced stage tumors, especially in tumors with rectal involvement.
dc.language.isoeng
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleInvestigation of Long Non-coding RNAs H19 and LINC00675 in Colorectal Cancers in Terms of Histopathological Features and Correlations With Plasma Markers
dc.typeMakale
dc.relation.journalANTICANCER RESEARCH
dc.contributor.departmentGaziantep Üniversitesi , ,
dc.identifier.volume42
dc.identifier.issue3
dc.identifier.startpage1301
dc.identifier.endpage1306
dc.contributor.firstauthorID3401925


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster